TrialJAMA oncology2019
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.
Erminia Massarelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
318 papers cite itlatest 60 shown
this paperpooled ittrialcites it